-
321
Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study
Published 2025-01-01“…Abstract Background Previous studies have confirmed the significant role of cathepsins in the development of neurodegenerative diseases. We aimed to determine whether genetically predicted 10 cathepsins may have a causal effect on Alzheimer's disease (AD), Parkinson's disease (PD), and amyotrophic lateral sclerosis (ALS). …”
Get full text
Article -
322
Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study
Published 2018-01-01Get full text
Article -
323
Emerging role of gut microbiota extracellular vesicle in neurodegenerative disorders and insights on their therapeutic management
Published 2024-12-01“…Vesicle components contact immune receptors, initiating neuroinflammatory immune responses and causing neurodegenerative diseases. This study seeks to explain how the gut microbiota and its extracellular vesicles cause or worsen neurodegenerative diseases. …”
Get full text
Article -
324
-
325
Kinetic Modeling of the Mitochondrial Energy Metabolism of Neuronal Cells: The Impact of Reduced α-Ketoglutarate Dehydrogenase Activities on ATP Production and Generation of Reacti...
Published 2012-01-01“…Reduced activity of brain α-ketoglutarate dehydrogenase complex (KGDHC) occurs in a number of neurodegenerative diseases like Parkinson's disease and Alzheimer's disease. …”
Get full text
Article -
326
Microglia and Synapse: Interactions in Health and Neurodegeneration
Published 2013-01-01“…However, in neurodegenerative diseases that are associated with misfolding and aggregation of synaptic proteins, these vital defensive functions appear to be compromised. …”
Get full text
Article -
327
Therapeutic Actions of the Thiazolidinediones in Alzheimer’s Disease
Published 2015-01-01Get full text
Article -
328
Relationship between Zinc (Zn2+) and Glutamate Receptors in the Processes Underlying Neurodegeneration
Published 2015-01-01“…Under clinical conditions, hyperactivity of the glutamate system is associated with ischemia, epilepsy, and neurodegenerative diseases such as Alzheimer’s, Huntington’s, and many others. …”
Get full text
Article -
329
An Ultrasound Prototype for Remote Hand Movement Sensing: The Finger Tapping Case
Published 2024-12-01“…In the context of neurodegenerative diseases, finger tapping is a gold-standard test used by clinicians to evaluate the severity of the condition. …”
Get full text
Article -
330
Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
Published 2025-01-01“…Neurodegenerative diseases are currently among the most devastating diseases with no effective disease-modifying drugs in the market, with Alzheimer’s disease (AD) being the most prevalent. …”
Get full text
Article -
331
Biomechanics Parameters of Gait Analysis to Characterize Parkinson’s Disease: A Scoping Review
Published 2025-01-01Get full text
Article -
332
Prevalence of delirium in German nursing homes: protocol for a cross-sectional study
Published 2025-01-01Get full text
Article -
333
-
334
Dysregulation of Metabolic Peptides in the Gut–Brain Axis Promotes Hyperinsulinemia, Obesity, and Neurodegeneration
Published 2025-01-01“…Furthermore, we review the potential links between these conditions and neuroinflammation and the development of neurodegenerative diseases like dementia, specifically Parkinson’s disease and Alzheimer’s disease.…”
Get full text
Article -
335
Thiamine and Thiamine Pyrophosphate as Non-Competitive Inhibitors of Acetylcholinesterase—Experimental and Theoretical Investigations
Published 2025-01-01“…It has been proven that supportive therapy with vitamin B<sub>1</sub> can not only provide neuroprotection but also has a positive effect on advanced neurodegenerative diseases, such as Parkinson’s disease, Alzheimer’s disease, Wernicke–Korsakoff syndrome, or Huntington’s disease. …”
Get full text
Article -
336
G6PD deficiency triggers dopamine loss and the initiation of Parkinson’s disease pathogenesis
Published 2025-01-01Get full text
Article -
337
Nanoparticle Therapy Is a Promising Approach in the Management and Prevention of Many Diseases: Does It Help in Curing Alzheimer Disease?
Published 2020-01-01“…Nanomedical application provides a promising drug delivery revolution for the treatment of neurodegenerative diseases (NDDs). It depends on improving the pharmacokinetic distribution of drugs through the central nervous system. …”
Get full text
Article -
338
Effect of a Traditional Chinese Herbal Medicine Formulation on Cell Survival and Apoptosis of MPP+-Treated MES 23.5 Dopaminergic Cells
Published 2017-01-01“…Taken together, these results provide a preliminary mechanism to support clinical application of the TCM formulation in PD and possibly other neurodegenerative diseases associated with ROS injury and apoptosis.…”
Get full text
Article -
339
Regenerative Medicine for Neurological Disorders
Published 2010-01-01“…The 16th ASNTR meeting focused on a variety of different topics, including the unknown pathogenesis or mechanisms of specific neurodegenerative diseases, stem cell biology, and development of novel alternative medicines or devices. …”
Get full text
Article -
340
Searching for the cellular underpinnings of the selective vulnerability to tauopathic insults in Alzheimer’s disease
Published 2025-02-01“…Abstract Neurodegenerative diseases such as Alzheimer’s disease exhibit pathological changes in the brain that proceed in a stereotyped and regionally specific fashion. …”
Get full text
Article